lactic acid has been researched along with s-nitroso-n-acetylpenicillamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, CH; Georgescu, HI; Stadler, J; Stefanovic-Racic, M | 1 |
| Hagino, Y; Matsui, S; Nomura, H; Nomura, T; Ohtsuki, M; Sumi-Ichinose, C | 1 |
| Allen, JC; Kahn, AM; Lichtenberg, DS; Seidel, CL; Song, T; Zhang, S | 1 |
| Borderie, D; Ekindjian, OG; Hernvann, A; Le Marechal, H | 1 |
| Boudier, A; Dupuis, F; Lartaud, I; Leroy, P; Maincent, P; Nouvel, C; Parent, M; Sapin, A; Six, JL | 1 |
| Lautner, G; Meyerhoff, ME; Schwendeman, SP | 1 |
6 other study(ies) available for lactic acid and s-nitroso-n-acetylpenicillamine
| Article | Year |
|---|---|
Nitric oxide and energy production in articular chondrocytes.
Topics: Animals; Arginine; Cartilage, Articular; Cells, Cultured; Cytokines; Energy Metabolism; Humans; Interleukin-1; Lactates; Lactic Acid; Nitric Oxide; omega-N-Methylarginine; Penicillamine; Rabbits; Recombinant Proteins; S-Nitroso-N-Acetylpenicillamine; Transforming Growth Factor beta | 1994 |
Nitric oxide donor NOR 3 inhibits ketogenesis from oleate in isolated rat hepatocytes by a cyclic GMP-independent mechanism.
Topics: Adenosine Triphosphate; Animals; Benzoates; Calcium; Cells, Cultured; Cyclic GMP; Imidazoles; Lactic Acid; Liver; Male; Molsidomine; Nitric Oxide; Nitro Compounds; Oleic Acid; Penicillamine; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Sodium Nitrite; Vasodilator Agents | 1998 |
Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential.
Topics: Aerobiosis; Animals; Cells, Cultured; Dogs; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Female; Glycolysis; Guanylate Cyclase; Immunoblotting; Insulin; Lactic Acid; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Oxidation-Reduction; Penicillamine; Pyruvic Acid; S-Nitroso-N-Acetylpenicillamine | 2000 |
Nitric oxide modifies glycolytic pathways in cultured human synoviocytes.
Topics: Cell Survival; Cells, Cultured; Deoxyglucose; Dose-Response Relationship, Drug; Glucose; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Hemoglobins; Humans; Lactic Acid; Nitric Oxide; Nitrites; Nitroprusside; Osteoarthritis; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Synovial Membrane; Tritium | 2000 |
Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?
Topics: Animals; Arterial Pressure; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Implants; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrrolidinones; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; S-Nitrosoglutathione; Telemetry; Triacetin; Vasodilation; Vasodilator Agents | 2013 |
Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery.
Topics: Delayed-Action Preparations; Drug Delivery Systems; Lactic Acid; Microspheres; Nitric Oxide; Nitric Oxide Donors; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; S-Nitroso-N-Acetylpenicillamine | 2016 |